In suspected myocardial infarction, why is aspirin often given in the prehospital setting?

In suspected myocardial infarction, why is aspirin often given in the prehospital setting?

• A. To inhibit platelet aggregation and prevent further clot formation.
• B. To dissolve the current clot immediately.
• C. To treat chest pain by soothing nerves.
• D. To raise blood pressure.

Answer: (A)

The key idea is that aspirin helps prevent a larger clot from forming in the coronary artery by blocking platelets. It does this by irreversibly inhibiting an enzyme in platelets (COX-1), which reduces the production of thromboxane A2, a chemical that promotes platelet activation and clumping. In the setting of suspected myocardial infarction, this early antiplatelet action slows or stops the growth of the clot that’s occluding a coronary vessel, improving blood flow and reducing death and damage while the patient waits for definitive reperfusion therapy. Aspirin does not dissolve an existing clot—that’s the role of clot-dissolving meds like thrombolytics or mechanical reperfusion. It also doesn’t directly treat chest pain by calming nerves, nor does it raise blood pressure. For these reasons, the rationale for giving aspirin prehospital is to limit clot progression and improve outcomes, not to dissolve the clot or alter blood pressure. In practice, a chewable dose of typically 160–325 mg is given to accelerate absorption and onset, assuming there are no contraindications such as allergy or active internal bleeding.

The key idea is that aspirin helps prevent a larger clot from forming in the coronary artery by blocking platelets. It does this by irreversibly inhibiting an enzyme in platelets (COX-1), which reduces the production of thromboxane A2, a chemical that promotes platelet activation and clumping. In the setting of suspected myocardial infarction, this early antiplatelet action slows or stops the growth of the clot that’s occluding a coronary vessel, improving blood flow and reducing death and damage while the patient waits for definitive reperfusion therapy.

Aspirin does not dissolve an existing clot—that’s the role of clot-dissolving meds like thrombolytics or mechanical reperfusion. It also doesn’t directly treat chest pain by calming nerves, nor does it raise blood pressure. For these reasons, the rationale for giving aspirin prehospital is to limit clot progression and improve outcomes, not to dissolve the clot or alter blood pressure. In practice, a chewable dose of typically 160–325 mg is given to accelerate absorption and onset, assuming there are no contraindications such as allergy or active internal bleeding.